Clinical cyp2d6 genotyping to personalize adjuvant tamoxifen treatment in er-positive breast cancer patients: Current status of a controversy

Tessa A.M. Mulder, Mirjam de With, Marzia Del Re, Romano Danesi, Ron H.J. Mathijssen, Ron H.N. van Schaik*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

25 Citations (Scopus)
51 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Clinical cyp2d6 genotyping to personalize adjuvant tamoxifen treatment in er-positive breast cancer patients: Current status of a controversy'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology